Cargando…
Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer
PURPOSE: To identify whether Dickkopf-1 (DKK1) could be a potential biomarker for early detection and prognosis in patients with pancreatic cancer (PC). METHODS: Serum was collected from 140 patients with pancreatic adenocarcinoma and 92 control patients without pancreatic adenocarcinoma. Serologica...
Autores principales: | Han, Su-xia, Zhou, Xia, Sui, Xin, He, Chen-chen, Cai, Meng-jiao, Ma, Jin-lu, Zhang, Yuan-yuan, Zhou, Cong-ya, Ma, Chen-xian, Varela-Ramirez, Armando, Zhu, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637329/ https://www.ncbi.nlm.nih.gov/pubmed/26101916 |
Ejemplares similares
-
Autoantibodies against glucose-regulated protein 78 as serological biomarkers in metastatic and recurrent hepatocellular carcinoma
por: Ying, Xia, et al.
Publicado: (2017) -
High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma
por: Zhou, Cong‐ya, et al.
Publicado: (2018) -
Serum Dickkopf-1 expression level positively correlates with a poor prognosis in breast cancer
por: Zhou, Shao-jie, et al.
Publicado: (2014) -
Elevated Levels of Dickkopf-1 Are Associated with β-Catenin Accumulation and Poor Prognosis in Patients with Chondrosarcoma
por: Chen, Changbao, et al.
Publicado: (2014) -
Relationship between serum Dickkopf-1 and albuminuria in patients with type 2 diabetes
por: Hou, Ning-Ning, et al.
Publicado: (2021)